$CTIX Up to date company activities and other important

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
$CTIX Up to date company activities and other important information about $CTIX

$CTIX

DD Notes ~ http://www.ddnotesmaker.com/CTIX

##### recent news/filings ~ source: finance.yahoo.com

Mon, 16 Dec 2013 14:06:06 GMT ~ Cellceutix: An Undiscovered Company Set To Rise In 2014
read full: http://seekingalpha.com/article/1900321-cellc...urce=yahoo
*********************************************************

Mon, 16 Dec 2013 12:00:00 GMT ~ Cellceutix Submits Application for IRB Review to Commence Phase 2b Clinical Trial of Novel Antibiotic Brilacidin
- Cellceutix Corporation , a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology, and antibiotic applications, is pleased to announce that it has submitted the ...
read full: http://finance.yahoo.com/news/cellceutix-subm...00295.html
*********************************************************

Mon, 09 Dec 2013 12:00:00 GMT ~ Cellceutix Updates on Current Status of Programs
- Cellceutix Corporation , a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology, and antibiotic applications, today updates shareholders on recent developments ...
read full: http://finance.yahoo.com/news/cellceutix-upda...00798.html
*********************************************************

Tue, 19 Nov 2013 10:38:12 GMT ~ 3 Innovative Biotech Companies Poised To Shine At TAP Partnership Conference
- The Annual Therapeutic Area Partnerships (TAP) is the industry's "most efficient partnering meeting for biopharmaceutical companies and executives seeking to understand the strategic outlook for new ...
read full: http://seekingalpha.com/article/1848141-3-inn...urce=yahoo
*********************************************************

Mon, 18 Nov 2013 12:00:00 GMT ~ Cellceutix Identifies Drug Candidates for Gram-Negative and Candida Fungal Infections
- Cellceutix Corporation , a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology, and antibiotic applications, is pleased to report that it has made significant ...
read full: http://finance.yahoo.com/news/cellceutix-iden...00393.html
*********************************************************

##### chart ~ source: stockcharts.com

stockcharts.com/c-sc/sc?s=CTIX&p=D&b=5&g=0&id=p95448242713

##### chart ~ source: eoddata.com

http://chart.eoddata.com/?e=OTCBB&s=CTIX&...D&b=BB

##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/CTIX/company-info
Ticker: $CTIX
OTC Market Place: OTCQB
CIK code: 0001355250
Company name: Cellceutix Corp.
Company website: http://www.cellceutix.com
Incorporated In: NV, USA

##### extra dd links

Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/CTIX/filings
Latest financials: http://www.otcmarkets.com/stock/CTIX/financials
Latest news: http://www.otcmarkets.com/stock/CTIX/news - http://finance.yahoo.com/q/h?s=CTIX+Headlines

Major holdings: http://data.cnbc.com/quotes/CTIX/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=CTIX+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/CTIX.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=CTIX

RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search

DTCC: http://search2.dtcc.com/?q=Cellceutix+Corp.&a...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...eutix+Corp.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.cellceutix.com
Alexa: http://www.alexa.com/siteinfo/http://www.cellceutix.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.cellceutix.com

http://www.pennystocktweets.com/stocks/profile/CTIX

##### last known share structure ~ source: otcmarkets.com

Market Value: $193,041,843 a/o Dec 13, 2013
Shares Outstanding: 104,914,045 a/o Nov 04, 2013
Float: Not Available
Authorized Shares: 300,000,000 a/o May 12, 2008
Par Value: 0.0001

##### business description ~ source: otcmarkets.com

An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers.

DD Notes ~ http://www.ddnotesmaker.com/CTIX

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Quantum Computing Stocks Surge: Analyst's Insights and Trends

Updated Category News Views 335

Quantum Computing Stocks Experience Remarkable Growth In recent times, the quantum computing sector has witnessed a remarkable surge, driven by strong retail investor enthusiasm and substantial government backing. This silver lining has propelled quantum stocks to unprecedented heights, with various analysts taking a closer look at key players in the industry. Among them,...

Continue Reading
Lucid Group Reports Impressive Q2 Production and Delivers Growth

Updated Category News Views 123

Lucid Group's Exciting Q2 Production and Deliveries Recently, Lucid Group, Inc. (NASDAQ: LCID), renowned for creating cutting-edge electric vehicles, unveiled its production and delivery numbers for the quarter ending June 30. This quarter reflected significant advancements, with the company producing a total of 3,863 vehicles and achieving deliveries of 3,309 vehicles....

Continue Reading
Upcoming Oracle Earnings: AI Strategies Under Scrutiny

Updated Category News Views 182

Preview of Oracle's Earnings Report Enterprise software leader Oracle is set to report its earnings soon, drawing attention from investors and analysts alike. In its previous quarter, the company showcased a revenue increase of 12.2% year-over-year, totaling approximately $14.93 billion. However, despite this growth, it fell slightly short of Wall Street expectations by...

Continue Reading
IQSTEL Set to Make Debut on NASDAQ Capital Market Tomorrow

Updated Category News Views 159

IQSTEL Inc. Set for NASDAQ Trading Launch IQSTEL Inc. (NASDAQ: IQST), a pioneering multinational technology firm based in the U.S., is thrilled to announce an important milestone in its evolution. The company is set to begin trading tomorrow on The NASDAQ Capital Market under the ticker symbol IQST. This exciting transition follows its successful tenure on the OTCQX...

Continue Reading
What to Expect: Garrett Motion's Upcoming Earnings Report

Updated Category News Views 61

Get Ready for Garrett Motion's Earnings Announcement Garrett Motion (NASDAQ: GTX) is gearing up to release its latest quarterly earnings report soon, and it has investors buzzing with anticipation. Market watchers are eager to gauge the company's financial health and how it will navigate the next quarter. What Analysts Are Predicting Forecasts indicate that Garrett Motion...

Continue Reading